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Peptide–membrane interactionBiomolecular-membrane interactions play a critical role in the regulation ofmany important biological processes
such as protein trafﬁcking, cellular signalling and ion channel formation. Peptide/protein–membrane interactions
can also destabilise and damage the membrane which can lead to cell death. Characterisation of the molecular
details of these binding-mediated membrane destabilisation processes is therefore central to understanding
cellular events such as antimicrobial action, membrane-mediated amyloid aggregation, and apoptotic protein
induced mitochondrial membrane permeabilisation. Optical biosensors have provided a unique approach to
characterising membrane interactions allowing quantitation of binding events and new insight into the kinetic
mechanism of these interactions. One of the most commonly used optical biosensor technologies is surface
plasmon resonance (SPR) and there have been an increasing number of studies reporting the use of this
technique for investigating biophysical analysis of membrane-mediated events. More recently, a number of
new optical biosensors based on waveguide techniques have been developed, allowing membrane structure
changes to be measured simultaneously with mass binding measurements. These techniques include dual
polarisation interferometry (DPI), plasmon waveguide resonance spectroscopy (PWR) and optical waveguide
light mode spectroscopy (OWLS). These techniques have expanded the application of optical biosensors to
allow the analysis of membrane structure changes during peptide and protein binding. This review provides a
theoretical and practical overview of the application of biosensor technology with a speciﬁc focus on DPI, PWR
and OWLS to study biomembrane-mediated events and the mechanism of biomembrane disruption. This article
is part of a Special Issue entitled: Lipid–protein interactions.
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The universal function of the biomembrane is the segregation of differ-
ent compartments, which enables the cell to establish andmaintain essen-
tial chemical and electrical gradients between the interior and the exterior
environment. Lipidmembranes act as an impermeable barrier, limiting the
direct crossing of ionicmolecules. Themaintenance of cell function thus de-
pends on well-controlled material exchange and interplay between pep-
tides/proteins and lipid species in membrane compartments of different
functions, leading to the evolution of awide range ofmembrane associated
channels, transporters, receptors, signalling molecules and cytoskeletons.
As a result, energy coupling, cell–cell recognition and communication, im-
mune response, biocompatibility andmanyotherprocesses are inextricably
associated with biomembrane structural integrity.
Biomembranes are complex colloid systems consisting of a wide
range of chemical compositions which determine the physical proper-
ties of various structures and organisation and therefore underpin the
characteristic biological function. The relative amounts of organic com-
ponents in membranes vary considerably between different organelles
and cell types, which contain on a dry weight basis 20–60% protein,
30–80% lipids and up to 10% carbohydrate. Themain categories of lipids
found in biomembranes are phospholipids, sphingolipids and sterols
where phospholipids constitute the major lipid components. These
lipid species are subjected to dynamic variation and their relative com-
positions are tightly controlled and maintained by regulatory networks
of lipid composition sensors [1–4]. The physical properties of a lipid
membrane such as surface charge, thickness, curvature, elasticity and
packing order are highly regulated to maintain the proper function of
different membranes [5]. The surface charge of membranes is deter-
mined by the relative proportions of phospholipid head groups
which are zwitterionic in phosphatidylcholine (PC) and phosphati-
dylethanolamine (PE) and anionic in phosphatidylserine (PS), phos-
phatidylinositol (PI), and phosphatidylglycerol (PG). In addition to
their effects on surface charges, the different volumes occupied by
these head groups and charge–charge repulsion impacts on the mem-
brane curvature and packing density. The bilayer thickness, elasticity
and structural packing of lipid molecules in the membrane are mainly
affected by the length and degree of unsaturation of the acyl chain.
There are also some low abundant phospholipids such as phosphatidy-
linositideswhichmediate speciﬁcmolecular recognition in receptor func-
tion, cellular secretion and membrane dynamics [6]. In addition to the
phospholipids, the presence of sphingolipids, mainly sphingomyelin and
glycosphingolipids, increases the packing density in the membrane
resulting in solid–gel phase properties at physiological temperatures [7,
8]. Conversely, the sterols interferewith the tight packing of fully saturat-
ed acyl chains rendering the membrane in a liquid–crystal state [7]. Due
to their condensing effect, sterols reduce the ﬂuidity of membranes com-
posed mainly of phospholipids with unsaturated acyl chains. Thus, mod-
iﬁcation of the composition of membrane lipids will affect the
physiological function of a membrane due to changes in impermeability.
Analysis of biomolecular interactions in themembrane environment
is central to understanding biochemical mechanisms. However, the
understanding of the complex physicochemical properties of biomem-
branes continues to be amajor challenge in the structural and functional
characterisation of peptides/proteins–membrane interactions. Al-
though many analytical systems have been established for measuring
inter-molecular interactions such as protein–ligand and protein–
protein interactions, these techniques are not readily applicable to char-
acterise the interactions between peptides/proteins and membranes.With recent developments in surface scanning and spectroscopic tech-
nologies, the structure, location and orientation of molecules relative
to the lipid bilayer, together with the binding afﬁnity and kinetics
have been the main focus in exploring the interaction of biomolecules
with lipidmembranes. These different aspects can be studied by various
spectroscopic and surface scanning techniques such as circular dichro-
ism (CD) [9–11], nuclear magnetic resonance (NMR) [12–14], Fourier-
transform infra-red (FTIR) [15,16], neutron reﬂectometry (NR) [17,18],
atomic force microscopy (AFM) [19,20], quartz-crystal microbalance
(QCM) [21,22], electron microscopy (EM) [23], ﬂuorescence spectrosco-
py, sum frequency generation spectroscopy [24,25], isothermal calorime-
try (ITC) [26,27], surface plasmon resonance (SPR) [28–30], ellipsometry
[31–33] and optical waveguide biosensors [34–37].
In spite of this battery of biophysical techniques, there is an enormous
gap in our understanding of themembrane-mediated interactions particu-
larly in view of the role of lipidmolecular organisation. This is partly due to
the lack of knowledge of the structure and physicochemical properties of
biomembranes, particularly in termsof the changes in theseproperties dur-
ing biomolecule binding, information which is central to characterising the
activity of membrane-associated peptides and proteins. Optical biosensors
provide label-free real-time qualitative and quantitative measurement of
biomolecule–membrane interactions [38]. However, no structural informa-
tion is provided by commonly used biosensor instruments such as SPR,
which is restricted to the measurement of mass-only differences [39].
Thus,whilst it iswell-established that themembrane is aﬂuid environment
with a constantly changing structure and composition, the structure of the
biomembrane is often the silent, invisible partner in the experimental anal-
ysis of membrane-mediated events. However, the optical waveguide tech-
niques [40–42] including dual polarisation interferometry (DPI), plasmon
waveguide resonance spectroscopy (PWR) and optical waveguide
light mode spectroscopy (OWLS) now provide the advantage of
multi-parameter measurements in a single binding assay which
yield the optogeometrical properties of density and thickness of
the adsorbed layer. The signiﬁcance of these features lies in the abil-
ity to now analyse the impact of membrane active peptides and pro-
teins on the structure of the bilayers simultaneously with the mass
changes associated with the binding event.
The aim of this review is to provide a theoretical and practical over-
view of the application of biosensor technology with a speciﬁc focus on
DPI, PWR and OWLS to study biomembrane-mediated events. These
techniques, which are based on an integrated planar optical waveguide
interferometer that combine evanescent ﬁeld sensing and optical phase
difference measurementmethods will be described in terms of the spe-
ciﬁc experimental outputs and the changes in physicochemical param-
eters of the bilayer that contribute to the sequence of events that
leads to the activity of peptides and proteins. Techniques for the prepa-
ration and deposition of bilayers onto the sensor chip surface and the
quantitative analysis of changes in binding and structural data will be
described. The power of these techniques will be illustrated by their
application to study a range of biological processes. Finally, new in-
sights into the mechanism of peptide and protein interactions with
membranes will be reviewed in terms of the different binding pro-
ﬁles that have been revealed by these techniques. Overall, these
techniques allow a new understanding of howmembrane character-
istics inﬂuence peptide and protein function as we can now deﬁne
membrane interactions in terms of changes in both the structure/
orientation of peptides and structure/organisation of membrane
lipids which will also impact on the development of new assay tech-
nology and drug design.
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2.1. Single versus multi-parameter measurements
Optical techniques have played an important role in the study of the
mechanisms and kinetics of molecular interactions in biological pro-
cesses, with instruments utilising evanescent ﬁeld sensing to monitor
molecular events occurring within 100–200 nm of a surface. Several
biophysical techniques have provided important information on
the relationship between membrane–active peptide and protein
structure and their biological function. SPR was one of the ﬁrst opti-
cal biosensors to be used in the analysis of membrane interactions
and several studies yielded detailed analysis of the kinetics and afﬁn-
ity of peptide–membrane interactions. Thus, the concentration mea-
surements and kinetics (association and dissociation) of molecular
interaction events have been widely used in delineating the binding
mechanisms [28–30]. SPR spectroscopy was also ﬂexible in terms of
the membranes studied, being applicable to biomembrane-based
systems using planar monolayers, planar bilayers or liposomes
[28–30].
Most techniques, including SPR, provide a single parameter mea-
surement in one independent assay based on the widely-used evanes-
cent wave method. As a consequence, the data obtained with these
techniques are limited to the measurement of mass-related changes
from the resonance angle shift as a function of time. However, the inter-
actions of biomolecules with a membrane involve both the mass-
related changes from the binding of peptides/proteins onto the mem-
brane and the impact of this binding on membrane structure. The
mass-response from a single measurement can be enhanced or sup-
pressed by the structural changes, for example, due to lateral expansion
or compression of the membrane. These structural changes in an aniso-
tropic system (such as a lipid bilayer) can be very complex and difﬁcult
to measure without speciﬁc labelling. To resolve the binding-promoted
membrane structural changes using an optical biosensor, two indepen-
dent orthogonal polarised ﬁelds at a ﬁxed wavelength or two evanes-
cent ﬁelds at different optical wavelengths allows the experimental
determination of two optogeometrical parameters (average refractive
index (RI) and thickness) of a uniform, isotropic thin ﬁlm. Different con-
ﬁgurations of waveguide-based optical sensors have employed either of
these two design principles to obtain the layer structure for further
studying the dynamic conformational changes associated with mem-
brane binding. These methods include plasmon waveguide resonance
spectroscopy (PWR) [43,44], opticalwaveguide lightmode spectroscopy
(OWLS) [37] and dual polarisation interferometry (DPI) [45,46]. The
physical basis of these three techniques is depicted schematically in
Fig. 1 and are described below.Fig. 1. Schematic diagrams of optical conﬁguration and data outputs of (a) PWR, (b)OWLS and (
a silverﬁlmoverlayeredwith a SiO2 ﬁlmmounted on a rotating table. Themethod involves the r
byvarying the angleɸ at aﬁxedwavelength and the PWR spectrum is recorded as the reﬂected l
s and p-polarizations. Molecular layers formed at the interface between the SiO2 surface and th
process. This results in changes in the intensity of the light reﬂected by the silver layer measur
Teﬂon spacer onto the silica surface and integralmembrane proteins can be inserted into the lip
per unit area and anisotropy) of the adsorbed lipid bilayer can be characterised and provides
ligand–receptor binding. (b) The optical waveguide light mode spectrometer (OWLS) consists
The grated waveguide chips are placed on the sensor holder and tightened onto a sealing O r
from a He-Ne laser at a given resonance angle is diffracted by an optical grating at the surfa
evanescent ﬁeld extending 100–200 nm from the surface. Incoupling of the incident laser beam
one for the transverse magnetic (TM) mode. Upon rotating the cuvette ±7°, four characterist
can be detected at the incoupling angles αTE and αTM. Changes in the refractive index for th
monitored in real-time by continuously measuring the shift of these incoupling angles. The cha
inducedmembrane structural changes. (c) The dual polarisation interferometer (DPI) consists o
waveguide and reference waveguide). Two orthogonal polarisations, TM and TE, pass through t
onto the surface. The changes for each TM and TE are detected separately as a phase shift in
liposome adsorption and the dynamic impact of peptide binding on the lipid bilayer structure
between the RI parallel to the surface (ne) and the RI perpendicular to the surface (no). The opt
unilamellar supported lipid bilayer. Thus, the changes in the packing, alignment and degree o
analysis of changes in birefringence. The correlation of membrane-bound peptide mass with b
of bound peptides on membrane structure.Spectroscopic ellipsometry is a widely used quantitative method to
measure the optogeometrical properties of thinﬁlms [47]. The thickness
and refractive index (RI) of the adsorbedmolecular layer can be derived
from the changes in amplitude (Ψ) and phase shift (Δ) of elliptically
polarised light upon reﬂection at solid–liquid interfaces. The adsorbed
mass derived from the RI can also be monitored in real-time for kinetic
measurements of biomolecular interactions [31–33]. The data analysis
requires careful selection of a speciﬁcmultilayer structuralmodel to cal-
culate the corresponding mass data, followed by data correction via an
error minimization process. However, the amplitude Ψ and phase
shift Δ can be affected by sample anisotropy and quantitative analysis
of this anisotropy has not yet been demonstrated for spectroscopic
ellipsometry and requires advanced generalised ellipsometry and
more complex ﬁtting models. Thus, whilst ellipsometry yields multi-
parameter outputs (i.e., mass, RI, thickness), the assumptions are
based on an isotropic layer and methods to analyse anisoptropic pro-
perties (e.g. peptide–membrane systems) have not yet been developed.
As a consequence, analysis of peptide–membrane interactions by
ellipsometry yield accurate mass-only data and cannot be extended to
the study of peptide-induced changes in membrane structure which is
possible with PWR, OWLS and DPI.
2.2. Plasmon waveguide resonance spectroscopy
Plasmon waveguide resonance (PWR) spectroscopy is a variant
of Kretschman-type SPR arrangement that involves more complex
assemblies in which surface plasmon resonances in a thinmetal (silver)
ﬁlm are coupled with guided waves in a dielectric silicon dioxide
overcoating, resulting in excitation of both plasmon andwaveguide res-
onances (Fig. 1a) [42,48]. The optical properties of thin-ﬁlm materials,
such as lipid–protein systems, including the thickness (t) and the com-
plex dielectric constant i.e. refractive index (n) and extinction coefﬁ-
cient (k) can be obtained from the surface resonances upon excitation
by both p- and s-polarised light components. The t, n and k values can
be uniquely evaluated from the spectra using a non-linear least-
square analysis to ﬁt a theoretical response curve to an experimental
curve. These parameters have allowed direct monitoring of the forma-
tion and evaluation of the quality of lipid bilayers including lipid rafts
[49–51]. When applied to membrane-bound receptors, such as G
protein-coupled receptors (GPCRs), PWR provides insight into the
dynamic receptor conformational changes associated with the changes
in membrane thickness and molecular packing of the lipid molecules
resulting from the interactions of structurally different ligands with
the same GPCR [42,44]. By measuring the shifts in the spectral reso-
nance minimum for s- and p-polarisations, different conformational
states in the human δ-opioid receptor, cannabinoid receptor and β2-
adrenergic receptor were induced upon binding of structurally differentc) DPI. (a) The plasmonwaveguide resonance spectrometer (PWR) consists of a prismwith
esonant excitation of plasmons by s andp polarised light froma CWlaser. Resonance occurs
ight intensity of the electricﬁeld of the excitation as a function of the incident angle for both
e aqueous compartment interact with this ﬁeld, thereby altering the resonance excitation
ed as a shift of the reﬂectance angle. A lipid bilayer can be anchored across the hole in the
id bilayer via detergent dilution. The structural properties (refractive index, thickness,mass
a platform for studying the afﬁnity and kinetics of peptide–membrane interactions and
of a grated waveguide and a ﬂow cell mounted onto the head of a precision goniometer.
ing which forms a ﬂow cell above the waveguide chip. A polarised monochromatic light
ce and propagates via total internal reﬂection inside the waveguide ﬁlm, generating an
occurs at two well-deﬁned angles of incidence: one for the transverse electric (TE) and
ic photocurrent peaks (one TE and one TM peak on both the positive and negative sides)
e formation of an adlayer of adsorbed biomolecules above the grating waveguide can be
nges of thickness and birefringence of the lipid bilayer provide information on the peptide
f a dual slabwaveguide guiding light through two high-refractive index structures (sensing
he waveguide forming two evanescent ﬁelds which are affected by themolecules binding
the fringe pattern at the far-ﬁeld. Thus, the formation of a unilamellar planar bilayer via
can be quantitatively analysed in real time. Birefringence is a measure of the difference
ical birefringence (Δnf) of a fully aligned/ordered bilayer is larger than that of a disordered
f order of lipid molecules assembled on the surface can be determined from quantitative
ilayer disordering provides new information in delineating the mechanisms of the impact
1871T.-H. Lee et al. / Biochimica et Biophysica Acta 1848 (2015) 1868–1885ligands including peptide, non-peptide agonists, antagonists and in-
verse agonists [44,52–56]. PWR has also allowed the determination of
the kinetics and thermodynamics of ligand binding to GPCRs for each
p- and s-polarisation and G-protein–GPCR interactions associated with
GDP/GTP exchange [43]. PWR can therefore provide unique information
on the correlation of ligand structures with distinct ligand-induced
changes in the shape and orientation of receptors in the membrane
underpinning the functional selectivity in G protein activation.
To characterise the complex spectra obtainedwith PWR, either spec-
tral simulation or graphical analysis is used to deconvolute themass and
structural changes induced by themolecular interactions in the lipid bi-
layers [49,57]. Spectral simulation has been used to obtain the structural
parameters such as thickness, average surface area per lipid moleculeand the degree of long rangemolecular order of lipid bilayers consisting
of single and binary lipids. PWR spectra obtained for the binary mixture
of PC (POPC or DOPC) with sphingomyelin (SM) revealed spontaneous
lateral segregation of lipids into microdomains with different optical
properties generating separate resonance in a PWR experiment with a
higher resonance angle for the thicker SM domain and smaller reso-
nance angles for the thinner PC domain [49,57]. The PWR spectra ob-
tained for the incorporation of the GPI-linked protein PLAP into the
binary PC/SM lipid bilayers then showed the selective interaction of
proteins with the thicker and more tightly packed SM-rich raft micro-
domain. These analyses further demonstrate the ability of PWR spec-
troscopy to follow the dynamic sorting of proteins in the membrane
bilayer [49,57].
1872 T.-H. Lee et al. / Biochimica et Biophysica Acta 1848 (2015) 1868–1885However, this ﬁtting analysis and spectral simulation do not pro-
vide a unique determination of the optical parameters for complex
spectra obtained from mixed modes of molecular interactions in-
volving multiple conformations that proceed either sequentially or
in a parallel series of events. In comparison, the graphical analysis
method transforms the plasmon-waveguide resonance spectral
shift obtained with both s- and p-polarised excitation in a (s–p) coor-
dinate system into a mass-structure anisotropy coordinate system
[58–60]. This method provides a simpler and faster route to distin-
guish between mass and anisotropy changes occurring in the pro-
tein–lipid bilayer ﬁlms than the spectral ﬁtting procedures. The
graphical method is thus used to deconvolute a complex sequence
of multiple events associated with the mass and structure changes in
the system, which cannot be accomplished using the spectral ﬁtting
procedure.
This analysis has been demonstrated for the peptide-induced
disruption of lipid bilayers from the spectral shift induced by cell-
penetrating peptides (CPP), such as penetratin and RL16, binding to
eggPC and eggPC/DOPE. Biphasic spectra were obtained for the binding
of penetratin to both eggPC and eggPC/DOPE involving two-state bind-
ing processes with the mass changes dominant in the ﬁrst event whilst
the second events were attributed to mass (80–90%) and structural
(20–10%) changes [58,61]. In contrast, these biphasic changes were
not obtained for the binding of penetratin to eggPC/DOPG or the binding
of RL16 to eggPC or eggPC/DOPG [58,62]. Themembrane interaction and
perturbation mechanism of another CPP, RW16, with a range of model
membranes including eggPC, DOPC, eggPC/POPG and DOPC/DOPS
were also investigated using PWR. Whilst membrane perturbation
was observed in each lipid, the afﬁnity constants of RW16 for each bilay-
erwere not affected by the lipid composition [59]. Overall, the structural
parameters derived using PWR spectroscopy that include changes in bi-
layer thickness, anisotropy and average refractive index have provided
new insight into the processes bywhich cell-penetrating peptidesmod-
ify the membrane structure during their passage through the lipid
bilayer.
2.3. Optical waveguide light mode spectroscopy
In optical waveguide light mode spectroscopy (OWLS), a grating is
coupled to a planar optical waveguide in which the polarised light is
diffracted from the grating and propagated via the internal reﬂections
inside the dielectric slab waveguide (Fig. 1b) [37]. Thewaveguide is de-
signed to simultaneously excite the zeroth-order transverse electric
(TE) and transverse magnetic (TM) polarisation modes when the
polarised light excites the waveguide at a particular incident angle.
The TE and TM resonance angles are separated from each other and
the effective refractive indices of the TM and TEmodes can be calculated
from those angles. As the evanescent optical waves of the mode extend
into thewaveguide cover, the adsorption ofmolecules on the surface re-
sults in a shift of the incidence angle for each TM and TE polarisation
modewhich can be quantitativelymonitored in real-time for kinetic analy-
sis. The optogeometrical properties, thickness and refractive index (RI), of
the deposited layers can then be extracted from themeasured effective re-
fractive indexby solving the3-layermode equations for thewaveguide sys-
tem. Themass per unit area (mass density) of the adsorbedmolecular layer
can be calculated from the thickness and RI. The grating-coupled optical
waveguides made of silicon titanium oxide (SixTi(1 = x)O2) are fabricated
with sol–gel technology. SiO2, TiO2, Ta2O5, ITO, ZrO2 and Al2O3, which are
applicable to various chemical and biochemical functionalizations, have
also been used in the coating on the sensor surface.
The optogeometrical parameters are calculated assuming that the
adsorbed layer is uniform (homogeneous) and isotropic. However,
lipid bilayers are an optically anisotropic system with a uniaxial optical
axis having two different principal refractive indices, the extraordinary
(ne) and ordinary (no). The measurement of the difference of ne and
no, known as optical birefringence, using the optical waveguide allowsthe intrinsic structure of the adsorbed biological ﬁlms to be studied at
the sub-nanometre scale since the optical birefringence of a membrane
reﬂects its level of structural organisation [31,63]. OWLS has been used
to characterise the adsorption of lipid vesicles onto smooth metal oxide
surfaces and the optical anisotropy of phospholipid bilayers with differ-
ent alkyl chains. It also allows measurement of the temperature depen-
dence of the optogeometrical parameters, thickness, RI and anisotropy
of a lipid bilayer [63]. The main phase transition temperature for a pla-
nar DMPC bilayer determined by OWLS is around 24 °C which agrees
with the value obtained by calorimetry [64,65]. The ability of OWLS to
measure the structural properties of lipid bilayers provides a useful
way to investigate the membrane partitioning of drugs [66], the dose
response of peptide hormones [67], the binding kinetics of peptides
and proteins to the bilayer [68,69] and ligand–receptor interactions by
incorporating transmembrane receptors [70].
2.4. Dual polarisation interferometry
In DPI, integrated planar optical waveguide interferometers com-
prise devices with two optical paths that measure optical phase dif-
ferences combined with evanescent ﬁeld sensing (Fig. 1c). The light
entering the waveguide structure of the interferometer passes through
both sensing and reference paths. Two different conﬁgurations, Young
and Mach–Zehnder interferometry, utilise the wave nature of light to
detect changes in the optical properties of a sample [35]. In a typical in-
tegrated optical interferometer, the interference of two light beams
conﬁgured with a Mach–Zehnder format is recombined by directing
them to the same path before reaching a photodetector. The intensity
of light is thus proportional to the square of the resulting amplitude of
two interfering waves. In Young's interferometer, the light emitted
from two slits of sensing and referencing paths are projected onto a de-
tector array forming an interference pattern captured by a high resolu-
tion recorder unlike in PWR and OWLS where signal intensity is
detected by a photodiode detector. In contrast to the common path
waveguide interferometer in which the light propagates on the same
waveguide (path), DPI comprises a double optical path Young interfer-
ometer conﬁguration in which waveguide modes propagate through
two vertically stacked single-mode waveguide layers (one sensing
and one reference waveguide layers) separated by a layer of cladding
material [45,46]. The reference waveguide is buried in the lower clad-
ding layer whilst the sensing waveguide samples the environment
through direct contact with the analytes. Polarised light from a laser
at a ﬁxed wavelength passes through both waveguides simultaneously
producing an interference pattern in the far-ﬁeld and detected by a CCD
camera. Direct measurement of the phase changes is obtained by con-
tinuously monitoring the relative phase position of the fringe pattern
by performing a Fourier transformation relating intensity to position.
The phase changes are related to the changes in the effective RI of the
sensing waveguide, allowing the detection of changes above the
upper surface of sensingwaveguide by the interaction of the evanescent
ﬁeld of the light with the material above the surface. Unlike SPR which
only utilises the TM polarisation, DPI is equipped with a polariser
switch which measures both the TM and TE polarisation sequentially.
Maxwell's equations of electromagnetism for a system of uniform
multiple dielectric layers are used to resolve the RI (or density) and
thickness of each layer from the absolute effective index of each TM
and TE polarisation. The optical anisotropy of a biological ﬁlm system
can also lead to an overestimation of the thickness values in DPI [71].
In these cases birefringence analysis has been developed to allow mea-
surement of the structural organisation of the adsorbed lipid bilayers
during their formation and destabilisation by membrane–active pep-
tides and proteins [71–73].
Overall, these optical sensors offer speciﬁc features to fully charac-
terise each single lipid bilayer system in terms of a range of dynamic
structural parameters including thickness, mass density per unit area,
surface area per lipid and molecular orientational order (birefringence
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of lipidmolecules is a distinctive feature allowingdetection and tracking
of changes in the structure of the lipid bilayer leading to greater under-
standing of the impact of biomolecules binding to a biomembrane. The
ﬂow-through system also allows kinetic analysis of the binding and
membrane disruption process in real time. Since the birefringence
quantiﬁes the degree of alignment and uniaxial packing of the lipid
molecules on the planar surface, changes in birefringence as a func-
tion of peptide binding to the membrane provide unique insight
into the mechanism of binding, and the rate and concentration-
dependent changes in lipid packing, domain formation and mem-
brane destabilisation.
As outlined in several previous studies [12,33,71–79], the underlying
assumptions of DPI data analysis have been well-documented. These
studies have shown that determination of both the RI and thickness of
the adsorbed ﬁlm in real time byDPI is valid for a homogenous isotropic
adsorbed ﬁlm. However, this condition is not fulﬁlled for biomolecular
assemblies with highly anisotropic polarizability such as lipid bilayers.
The dominating contribution to the optical response for a supported
lipid bilayer (SLB) is from the difference in the molecular polarizability
of the linearly polarised optical waveguidemodes TM and TE. These dif-
ferences in the polarizability of the two modes lead to three unknown
parameters that need to be determined for the SLBs, ie, thickness, re-
fractive index and birefringence (the difference between the effective
refractive indices of the two principal axes, or optical anisotropy).
However, only two parameters can be determined from two orthogonal
polarizations in DPI. To obtain two parameters for three unknown pa-
rameters, one of the three parameters is ﬁxed (assumed to be constant).
Thus, either RI or thickness is ﬁxed to calculate the birefringence. In
order to examine the effect of the molecules on the structural organisa-
tion of lipid bilayers adsorbed on a planar solid support, changes in bire-
fringence, thickness and hence mass of the layer were determined by
assuming a ﬁxed RI of 1.47 for the bilayer [12,33,71–78]. The birefrin-
gence and mass of the bilayer can also be calculated by assuming a
ﬁxed thickness of 4.7 nm as used in other works [71,80,81]. However,
both theoretical and experimental validations of this assumption has
shown that invalid mass and thickness values are derived if an isotopic
adlayermodel is used (without taking the anisotropy into account) [71,
77,79]. A number of studies have therefore used the thickness to deﬁne
the quality of the deposited membrane and then focused on changes in
birefringence during peptide binding. This approach has revealed more
details about the effect of the peptide on themembrane structure than a
change in thickness and allows the mechanism of action to be more
clearly deﬁned as outlined in the Sections below.
A subject of intense debate has been the presence and thickness of a
stratiﬁedwater layer between the substrate and supported bilayers. The
calculation of the water layer between the substrate and the supported
bilayer has been compared using DPI and QCM-D [82]. It was reported
that themass of only theDOPCbilayer excluding themass of any solvent
incorporated in the bilayer could be resolved byDPI. Themass contribu-
tion of the coupled solvent between the DOPC bilayer and the solid sup-
port was measured by QCM-D. By comparing these two methods, the
thickness of the hydration layer was 10.46 ± 0.15 Å for trapped D2O
and 10.21±0.40 Å for trappedH2O. TheDPImeasurement is insensitive
to solvent, thus only the mass of lipid bilayer adsorbed to the surface is
determined and does not include the bulk solvent or the trapped layer
of hydrationwhich can impact on themeasurements by othermethods.
3. Membrane preparation and deposition onto the sensor
chip surface
The investigations ofmembrane-mediated processes have advanced
the development of model membrane systems that allow interrogation
with various biosensingmethods. In order to fully exploit these speciﬁc
features of waveguide-based optical sensors (DPI, OWLS and PWR) to
study peptide–membrane interactions, it is essential to establishmembrane preparation protocols which provide structurally deﬁned
defect-free membranes with highly reproducible properties. Although
the heterogeneous and complex components in natural biomembranes
directly isolated from cells of living organisms are the ideal template,
use of thosemembranes in a biosensor environment is technically chal-
lenging. As a result, artiﬁcial membranemodel systems are used, which
still provide valuable complementary information on the physicochem-
ical properties and structural roles of individual lipids in membrane-
related activity and the effects of lipid bilayers on the binding character-
istics, structure and activity of peptides and proteins. Supported lipid
bilayers and tethered liposomes are two of the most commonly used
membrane models in studying membrane–mediated processes. Sup-
ported lipid bilayers, which are physisorbed onto a planar substrate,
provide the most applicable and direct method for optical biosensing
systems.
Several methods have been commonly used for the formation of
supported lipid bilayers (SLBs) on the surfaces of either unmodiﬁed or
chemically modiﬁed sensor chips. In the ﬁrst type of solid supported
membrane, lipid bilayers are adsorbed onto a hydrophilic surface by
transferring a lipid monolayer formed at the air–water interface using
the Langmuir–Blodgett and Langmuir–Schaefer deposition techniques
[83,84]. This method has been used to prepare the lipid bilayers for
the OWLS system [63]. The properties of the adsorbed bilayer prepared
by the Langmuir–Blodgett (LB) techniques are strongly dependent on
the preparation of a stable, well-compressed and homogeneous lipid
monolayer on the Langmuir trough. It also provides advantages in pre-
paring asymmetric bilayers with a different lipid composition in each
monolayer and incorporating lipids with large chemically-modiﬁed
head groups such as lipopolysaccharides in the outer monolayer only.
The residual organic solvent used in the spreading of lipid solution on
water is the one of the main concerns in preparing the bilayers with
highly reproducible packing organisation. Incorporation of proteins
into the bilayers can be complicated by denaturation as theymay be ex-
posed to air before transferring with themonolayer. An alternative way
to incorporate proteins is via fusion of receptor-associated vesicles or
micelles into the already deposited lipid bilayers.
A secondmethod for preparing the lipid bilayers on a chip surface in-
volves the adsorption and fusion of unilamellar lipid vesicles from an
aqueous suspension onto the substrate [83,84]. This is a relatively easy
and direct method which has been used to prepare lipid bilayers in
OWLS and DPI systems as shown in Fig. 2. Several factors can affect
the adsorption, collapse and fusion/spreading of lipid vesicles into bilay-
ers [83–85]. These factors involve the type, smoothness and cleanness of
the substrate; types, pH and ionic strength of buffer; adsorption temper-
ature; size, composition, surface charge and concentration of the lipid
vesicles. The addition of 1–2 mM Ca2+ or Mg2+ is also critical to assist
the adsorption of lipid vesicles and stabilisation of ﬁnal lipid bilayers
[85]. Understanding the role of these factors allows the establishment
of experimental conditions to obtain a defect-free unilamellar bilayer
and to avoid the imperfect structural mixture of vesicles and bilayers
on the chip surface. The formation and ﬁnal structural properties of
SLBs consisting of a wide range of lipid compositions have been fully
characterised by DPI and OWLS [63,71,78].
An alternativeway to prepare supported lipid bilayers is via prepara-
tion of a black lipid membrane [44,86]. As in PWR, the lipid bilayers are
formed in a small Teﬂon oriﬁce separating two compartments contain-
ing aqueous solutions. Lipids dissolved in organic solvent spread across
the Teﬂon oriﬁce, resulting in the initial orientation of lipid head groups
towards the silica surface in the prism. An annular plateau-Gibbs border
of lipid solution anchoring themembrane to the Teﬂon spacer is formed
after the addition of aqueous buffer into the sample cell. This border of
lipids provides membrane ﬂexibility allowing the bilayer to expand
and deform upon the insertion of peptides and proteins.
The ability to characterise bilayer formation in real time prepared by
differentmethods by PWR, OWLS andDPI is important to determine the
experimental conditions to control the structural properties of the
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characterised in terms of a range of dynamic structural parameters in-
cluding thickness/density, mass, lipid surface area, and orientational
order. The values of selected structural properties for lipid bilayers of
various compositions using DPI are listed in Table 1. These values corre-
late closely with the reported values obtained from X-ray reﬂectivity
and neutron reﬂectivity studies [87]. This degree of quantitative charac-
terisation of the bilayer structure enables the real time action of
membrane-active peptides and proteins to be accurately probed in
terms of alterations in the dynamic structure of the bilayer.
In addition to the unilamellar bilayer adsorbed onto the chip surface,
membranes have also been tethered onto modiﬁed chips as tethered li-
posomes [76,80]. The tethered liposome not only allows the incorpora-
tion of transmembrane receptors to study ligand-induced receptor
activation/inhibition, but also allows for the membrane destabilisation
mechanisms by insertion or rupture induced by peptides/proteins to
be differentiated.
Understanding the role of dynamic transbilayer asymmetry is of
particular importance in exploring the relationship between bio-
membrane structure and various cellular processes and in engineer-
ing biomembranes as biomaterials. Studies have demonstrated the
asymmetric distribution of lipid composition in SLBs can be formed
via direct vesicle adsorption–fusion [88–90]. The extent of lipid mo-
bility, lateral distribution and transbilayer asymmetry of the SLBs is
highly dependent on the lipid composition (charge density, acyl
chain length and degree of unsaturation and classes i.e. phospholipids,
sphingolipids, sterols). Lipid asymmetry is also strongly affected by
the physical properties of underlying solid surfaces, membrane prepa-
ration methods, vesicle fusion conditions and can vary within typical
experimental timescales. For example, the mobility of PS in lipid bilay-
ers formed on TiO2 is restricted in the presence of calcium ions whilst
the mobility of zwitterionic PC is not affected [51]. In contrast, both PC
and PS are mobile in the bilayer formed on SiO2. The preparation of
stable asymmetric bilayers therefore remains challenging in terms of
producing well-controlled and reproducible SLBs. Bilayer asymmetry
can also be induced by the phospholipid molecules binding to the SLBs.
For example, the methyl-β-cyclodextrin-mediated lipid exchange
technique has been applied to prepare asymmetric SLBs containing
sphingomylin and can also be prepared in the presence of a reconstituted
glycosylphosphatidylinositol-anchored protein [75]. DPI and QCM-D
have also been used in combination to monitor the mass and bire-
fringence changes for lipid ﬂip-ﬂop induced by the temperature-
dependent phase transitions in asymmetric SLBs on TiO2 [91].
4. Characterisation of peptide binding and changes in the
bilayer integrity
The changes in the optical thickness and mass obtained in real time
represent an overall signal response corresponding to the layer forma-
tion. This mass or thickness alone does not reveal the dynamic changes
in the structure of the lipid bilayers. Amongst various types of thin ﬁlms,
phospholipid bilayers show differences in RI for two orthogonal pola-
risations owing to the liquid crystal properties of lipid molecules self-
assembled into uni-axial aligned bilayers. The ordered orientation of
lipid molecules in a membrane therefore creates an anisotropic system
with a unique optical anisotropic property, where two principal RIs, ie,
ne and no in a uniaxial optical axis are different. The difference between
these two RIs for a lipid ﬁlm is deﬁned as the birefringence (Δnf) as
Δnf = ne − no. Thus, the degree of molecular order, S, of the uniaxial
lipid bilayer is deﬁned by the ratio of the principal polarizabilities of
the bilayer to the molecular polarizabilities [86]. This order parameter
(S) is proportional to the birefringence values. Thus, the birefringence
values represent an averaged measurement of lipid molecular orienta-
tion order and the lipid acyl chain packing order. High Δnf values are
obtained for a fully aligned lipid bilayerwhereas lowΔnf indicates a ran-
dom and disordered lipid bilayer. The birefringence values obtained forplaner lipid bilayers with various compositions are shown in Table 1. A
typical bilayer has a birefringence of 0.01–0.02 refractive index units.
The values are higher in the bilayers with fully saturated acyl chains
than in those bilayers with unsaturated acyl chains. DPI canmeasure re-
fractive index increments with high sensitivity and can therefore char-
acterise very subtle dynamic changes in orientation and packing order
of lipidmolecules, revealingmechanisms of interaction that are difﬁcult
if not impossible to see by other means. In summary, birefringence pro-
vides a directmeasurement of the quality of the bilayer itself and chang-
es in the birefringence value reﬂect changes in the bilayer structure as it
undergoes phase transitions or interactions with other molecules such
as proteins, polymers or ions. The ability to measure birefringence is
themost signiﬁcant feature of theDPI instrument in terms of investigat-
ing membrane-mediated events.
The ability of a waveguide-based biosensor to measure both mass
and birefringence simultaneously allows the analysis of the relationship
between the two properties to bemeasured in the interactions between
peptides/proteins and lipids. In the ﬁrst instance, plots of mass versus
time (Fig. 1c) yield information on binding which is analogous to
other optical biosensors such as SPR. However, dependence of birefrin-
gence on time (Fig. 1c) provides new information on the simultaneous
changes in membrane structure during the binding event. More signiﬁ-
cantly, the combination of these plots to give the birefringence vs. mass
plots (as illustrated in Fig. 3) reveals an enormous amount of new infor-
mation. In particular, a number of transitions can be described which
can be used to evaluate peptide behaviour and mechanism of action.
Both the initial binding of an analyte (such as a peptide), and any subse-
quent processes, may affect both themass and structural ordering of the
membrane, and the relationship between the two can be visualised
using the plot of birefringence vs. mass. Binding always involves some
increase in mass (at least initially) and may also be accompanied by
changes in birefringence. For a decrease in birefringence (and hence
and increase in membrane disorder), changes in the slope of the bire-
fringence–mass graph provides a measure of the effect that bound
molecules have on a membrane—from a horizontal to shallow slope
representing a surface binding that has only a small effect on birefrin-
gence, through a near vertical decrease for a substantial interruption
of the membrane structure, with other cases that fall between the two
extremes (Fig. 3). Alternatively, binding may also cause an increase in
birefringence, suggesting that a stabilising or ordering effect is occur-
ring. Membrane changes subsequent to binding may include dissocia-
tion from the membrane with recovery in birefringence or mass loss
with further decreases in order. This last possibilitymay indicate normal
dissociation combined with a slow decrease in birefringence from pep-
tide already bound, or it may indicate the loss of mass from the surface,
either by membrane thinning and spreading or the removal of material
from the surface. With the study of appropriate model systems, it may
become possible to characterise peptide–membrane interactions direct-
ly by observing the dynamic relationships between mass and structural
organisation. This would be an extremely powerful method for enhanc-
ing understanding of peptide–membrane interactions.
5. Proﬁling of lipid perturbation process and disruption by
membrane active peptides
Analysis of mass-birefringence plots, derived from the phase chang-
es of DPI and (s, p) coordinate systems, containing bothmass and struc-
tural axis placed according to the sensitivity factor of the PWR sensor
reveals the changes in membrane ordering that occur during peptide
binding. Suchmass-birefringence analysis allows very detailed and sub-
tle differences in the interactions between different lipid membranes
and peptide sequences to be deﬁned. This graphical analysis of the
correlation between binding and structural changes has been used to
evaluate the accumulated impact of a number of peptides to effect pro-
gressive changes in membrane structure. The birefringence analysis
provides unique real-time information on the impact of peptides on
Fig. 2. The kinetics of bilayer formation via direct liposome adsorption characterised by DPI. A faster rate of liposome adsorption is obtained within the ﬁrst few seconds of injection. The
adsorption rate slows down asmore liposomes saturate the chip surfacewhere collapse or deformation of liposomes occurs and the birefringence increases. The rate drops to nearly zero as
the bilayer forms on the surface with a high birefringence.
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in describing the behaviour of membrane-active peptides when inter-
acting with membranes of different lipid compositions. Knowledge of
the membrane structure changes signiﬁcantly informs our understand-
ing of biological processes categorised based on their activity in mem-
brane environment with speciﬁc examples including antimicrobial
peptides, amyloid peptides and apoptotic peptides are described below.
5.1. Antimicrobial peptides
Antimicrobial peptides (AMPs) are a class of peptides which act
against pathogenic microorganisms, mostly by a direct-killing mecha-
nism, but some AMPs act as immunomodulators in chemotaxis, angio-
genesis and regulation of the T cell response. The membranes ofTable 1
Structural properties of unilamellar SLBs determined using DPI.
Lipids Ratio Thickness (Å)
DMPC 100 45.2 ± 0.7
DMPC/DMPG 80:20 47.6 ± 1.6
DMPC/DMPG/Chol 64:16:20 34.6 ± 0.6
DMPE/DMPG 80:20 43.7 ± 5.0
DMPC/DMPS 80:20 47.5
POPC 100 48.7 ± 1.5
POPC/POPS 80:20 46.9 ± 0.6
POPC/POPS 75:25 38.1 ± 6.0
POPC/POPG 80:20 45.4 ± 0.4
POPC/POPS/POPE 60:30:10 46.9 ± 1.3
POPC/POPS/POPE 60:20:20 47.9 ± 0.1
POPC/POPE/POPS/PI 50:30:10:10 44.8 ± 0.6
POPC/POPE/POPS/PI/CL 48:20:10:10:4 48.9 ± 1.8
POPE/POPG 80:20 42.5
DOPC 100 46.0 ± 3.0
46.7 ± 2.6
DOPG 100 34.7 ± 3.9
DOPC/DOPE/DOPS 20:50:30 52.0 ± 3.0
DOPC/DOPE/DOPS 50:20:30 46.0 ± 2.0
DOPC/DOPS 80:20 52.9 ± 0.1
70:30 45.0 ± 4.0
DOPE/DOPG 75:25 45.0 ± 3.0
SoyPC/DOPE/Chol 60:30:10 46.3
LPS on DOPE/DPOG
E. coli extract 58.3 ± 1.3pathogens have been considered as the main target of AMPs for their
direct-killing activities. The interaction of AMPs with a membrane can
result in structural and topological changes in peptides and perturba-
tion of membrane integrity. Complex factors determine the activities
of AMPs in destabilisingmembrane structure and function and the abil-
ity of AMPs to discriminate between pathogen and host cell mem-
branes. Delineating the mechanisms of AMPs action thus requires the
dynamic changes in membrane structure to be characterised quan-
titatively in response to the peptide structural properties. Various mo-
lecular models have now been used to describe the AMP action on
membrane. As reviewed earlier [94,96], the molecular models range
from structurally deﬁned classical mechanisms such as barrel-stave,
toroidal and detergent-like carpet models to structurally less deﬁned
non-membranolytic mechanisms, such as sinking raft [32,97], lipidBirefringence Mass (ng/mm2) Reference
0.0217 ± 0.0006 4.53 ± 0.08 [73,78]
0.0235 ± 0.0015 4.77 ± 0.16 [73,78]
0.0164 ± 0.0003 3.47 ± 0.07 [73]
0.0244 ± 0.0028 4.34 ± 0.49 [73]
0.0231 4.75 [73]
0.0185 ± 0.0007 4.71 ± 0.15 [71,72]
0.0195 ± 0.0001 [71]
4.07 ± 0.20 [92]
0.0177 ± 0.0011 4.56 ± 0.05 [72]
0.0176 ± 0.0015 4.70 ± 0.12
0.0197 ± 0.0002 4.79 ± 0.01
0.0176 ± 0.0005 4.47 ± 0.07 [93]
0.0198 ± 0.0001 4.88 ± 0.33 [93]
0.0226 4.25
0.0170 ± 0.0010 4.60 ± 0.30 [76]
0.0149 ± 0.0005 4.70 ± 0.23 [94]
0.0124 ± 0.0025 3.30 ± 0.54 [94]
0.0191 ± 0.0007 5.20 ± 0.30 [76]
0.0172 ± 0.0004 4.60 ± 0.20 [76]
0.0250 ± 0.0019 [71]
0.0158 ± 0.0002 4.52 ± 0.04 [76]
4.40 ± 0.30 [32,75]
0.0135 4.63 [95]
0.7 [32]
0.0195 ± 0.0020 5.83 ± 0.07 [73]
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phases [8,20,41].When considering thesemodels it is possible thatmul-
tiplemodes of actionmaybe present simultaneously, and that themode
of action (if any) may be dependent on variable factors such as the con-
centration of peptides in solution and membrane-bound, the lipid
membrane composition and structure, the kinetics of binding and struc-
tural changes of all interacting partners.
The structural characteristics of an adsorbed lipid bilayer obtained
from the DPI waveguide-based biosensor offers a unique quantitative
analysis of membrane perturbation mechanisms for AMP action. Most
AMP binding results in an essentially linear decrease in the bilayer bire-
fringence with increasing peptide mass bound to membrane. As shown
in Fig. 3 for HPA binding to DMPC/DMPG (80:20) and citropin 1.1 bind-
ing to DMPC, this decrease in birefringence immediately after peptide
binding is a characteristic pattern for peptides incorporated into the
membrane without a threshold on the membrane surface [78]. These
patterns have been observed for aurein 1.2 binding to E. coli lipid extract
and DMPE/DMPG [73], HPA3 and HPA3P binding to DMPC and DMPC/
DMPG [78], peptides derived from various coagulation factors binding
to DOPE/DOPG [33], C-terminal peptides from S1 peptidases to DOPE/
DOPG [33], novicidin to DOPC/DOPG [98], KYE28, KYE21 and NLF bind-
ing to DOPE/DOPG [75], citropin 1.1, maculatin 1.1 and caerin 1.1 bind-
ing to DMPC [99]. However, this linear decrease in birefringence with
increased peptide mass seen in one membrane can becomemore com-
plexwith changes in either peptide sequence or changes in lipid compo-
sition. The binding of HPA3 and maculatin 1.1 to the gel-DMPC bilayer
displayed similar linear behaviour with bilayer structural disordering
[12,17,72,78]. However, the helical kink in maculatin 1.1 induces a bi-
phasic change with initial increases in membrane-bound peptide mass
without signiﬁcant bilayer disorder followed by an abrupt non-linear
disordering with further increases in mass upon binding to the ﬂuid
DMPC bilayer (Fig. 3). In contrast, the linear helical HPA3 showed a lin-
ear decrease in bilayer order with the gel-DMPC/DMPG bilayer (Fig. 3).
These studies clearly demonstrated that the role of proline in bilayer
perturbation can be delineated by the changes in birefringence which
is not possible by mass-only measurements. These distinctively differ-
ent features in binding to DMPC/DMPG, despite similar binding behav-
iourwith DMPC betweenHPA3 andmaculatin 1.1, also demonstrate the
importance in differentiating the membrane structural changes from
the peptide binding, since in the absence of the birefringence data, the
main conclusion would be that both peptides have similar binding
mechanisms.
The birefringence–mass proﬁles can also provide signiﬁcant new
insight that redeﬁnes current models of AMP action [73,74,99]. In partic-
ular, the sequential steps of binding, insertion and bilayer disruption can
be examined in real time at continuous increments of peptide:lipid (P:L)
ratio.Whilst many studies focus on deﬁning the critical concentration for
membrane destruction, characterising the steps associatedwith different
extents of bilayer perturbation at a distinctive P:L threshold provides a
much clearer understanding of the action of AMPs on the membrane.
Aurein 1.2 and magainin 2 are naturally found in the dorsal secretion of
an Australia tree frog and an African frog, respectively. Despite the differ-
ence in sequence and in particular the length,with 13 and 23 amino acids
for aurein 1.2 and magainin 2, respectively, both peptides adopt an am-
phipathic helix in an anionicmembrane environment,whilst no structure
was found formagainin2 in aneutralmembrane environment. The carpet
mechanism has been proposed as the mechanism by which both pep-
tides lyse membranes based on similar critical peptide:lipid (P:L) ratios
measured by conventionalmeans. However, DPI can provide information
on membrane structure changes immediately prior to, during and after
membrane lysis and signiﬁcant differences are apparent for these two
peptides which are described as acting by the same mechanism. Firstly,
the P:L ratio determined at the point of disruption for an anionic mem-
brane was markedly lower for aurein 1.2 than for magainin 2 (Fig. 3 &
Table 2). Moreover, an alanine-substituted analogue, Ala8,13,18-mag2
with enhanced bactericidal activity also showed anionic membranedisruption at a P:L ratio similar to magainin 2. However, the Ala8,13,18-
mag2 also disrupted the neutral DMPC membrane (Figs. 3 & 4) at nearly
double the P:L ratio. From the P:L ratio determined at the point of mem-
brane disruption, a “carpet mechanism” would be simply attributed to
themechanisms of action of these frog peptides. However, the drop in bi-
refringence was reversible for aurein 1.2 after its disruption of both neu-
tral DMPC and anionic DMPC/DMPGmembranes [73,74,99]. In contrast, a
partially reversible birefringence drop with permanent disordering was
obtained for Ala8,13,18-mag2 after membrane disruption. These partially
reversible birefringence changes with membrane disruption correlated
with the peptide insertion and bilayer expansion as evident from AFM
studies (Fig. 4) and both ﬂuorescence dye release and AFM results
showed that aurein 1.1,magainin 2 andAla8,13,18-mag2 disrupt themem-
brane differently [73,74,99]. Overall, these experiments clearly demon-
strate that deﬁnition of AMP action in terms of a speciﬁc model is too
simplistic. In particular, the reversible packing disorder–order behaviour
observed for different bilayers is quite distinctive for various AMPs, be-
haviour which is not apparent with other spectroscopic techniques. The
analysis of membrane disordering has therefore extended our under-
standing of how themembrane undergoes a reversible structural change
upon exposure to antimicrobial peptides and how the bilayer can either
recover or, at a critical peptide concentration, begins to disintegrate.
The activity of antibacterial polymers on the SLBs has been moni-
tored by the in situ changes of optical birefringence obtained by OWLS
[77]. The calculation of layer thickness and birefringence values was
based on an anisotropic adlayer model whilst the correlation of layer
thickness and birefringence was assessed comparatively with a
composite/exchange model. The addition of antibacterial polymer
to a bilayer resulted in initial increases in thickness from 5.2 nm to
8 nm and decreased to 5.8 nm whilst the birefringence decreased
from 0.026 to −0.06. This clearly showed the disordering effect
and lipid disintegration in response to the antibacterial polymer.
Based on the composite model, the surface coverage of antibacterial
polymer in the ﬁnal structure was also calculated with less than 40%
of the area covered with lipids at the end of the measurement.
Selectivity towards speciﬁc target cells is crucial to develop new
AMPs and other therapeutic agents acting on the membrane. The bind-
ing of peptides tomodelmembranes with known lipid composition and
structural properties has demonstrated the complex interplay between
charge, hydrophobicity, amphipathicity, bilayer structural organisation,
presence of sterol, sphingomyelin and sterol etc. in mediating binding
selectivity. In addition, modiﬁcation of peptide sequence, length, end-
tagging with a stretch of either charged or hydrophobic residues can
also enhance the selection towards pathogenic bacteria without toxicity
towards host cells. Studying the selective binding of peptides to natural-
ly occurring cell membrane is still limited to whole cell binding assays
and liposomes derived from cell membranes. The preparation of natural
membranes on solid supports for biosensor applications still remains a
challenge in terms of their stability and reproducibility.
What we can conclude is that these peptides have signiﬁcantly dif-
ferent binding properties and that these differences relate to differences
in the effect on membrane structure, and that the bioactivity of these
peptides is likely to be mediated by signiﬁcant changes in membrane
structure, which has not been previously demonstrated. More direct
correlations will be possible when birefringence measurements of bac-
terial membrane extracts are performed.
5.2. Amyloids
The association of misfolded protein and peptide aggregates with
neuronal cell membranes may play a key role in their neurotoxicity in
several degenerative disorders, but the underlying mechanisms of
amyloid growth and toxicity are still not fully understood. Formation
of amyloid aggregates has been studied by DPI which showed that ag-
gregation ismediated by various types of surfaces and the kinetics of ag-
gregation is signiﬁcantly enhanced upon adsorbing on a hydrophobic
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Fig. 3. Analysis of changes in bilayer order (as measured by the birefringence, Δnf) as a function of membrane-bound peptide mass (mp) allows the impact of peptide binding on the
membrane structure to be determined for various sequential steps corresponding to surface binding, partial-full insertion, membrane expansion andmembrane lysis, whereby decreases
inΔnf correspond to disordering inmembrane structure. (a) binding of human blood coagulation factor,mononine, to the supported POPC/POPS (80:20) bilayer showed a large amount of
protein mass bound to the membrane without signiﬁcant changes in birefringence; (b) magainin2 induces disorder in DMPC bilayer above a threshold concentration and this disorder is
fully reversible after peptide dissociation; (c) the accumulative binding of a peptide corresponding to the transmembrane domain of Bax protein to POPC showed increases in mass with
little increase in POPC order. (d, e) The insertion of citropin1.1 and maculatin1.1 to DMPC bilayer showed no changes in bilayer order at low peptide concentration whilst signiﬁcant
disorder in bilayer were determined as peptide concentration increased. In contrast, (f) the insertion of HPA peptide into DMPC/DMPG (80:20) induced signiﬁcant irreversible bilayer
disorder with a low membrane-bound peptide mass. (g) The lysis of DMPC membrane by aurein1.2 showed multiple sequential changes in bilayer disorder where the birefringence
returned to the starting valuewith signiﬁcant loss in overallmass;whilst (f) binding ofmaginin 2 analogue (Ala8,13,18-mag) to DMPC showed signiﬁcantmass losswith irreversible bilayer
disordering as a result of bilayer expansion. (i) Binding of a peptide corresponding to the transmembrane domain of Bak protein to a mitochondrial membrane mimic (POPC/PS/PE/PI/
CL = 52:10:10:4:4) showed signiﬁcant irreversible bilayer disordering with increasing membrane-bound peptide mass. (Compiled from references [12,72–74,78,93,99]).
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the very early stages of Aβ40 and Aβ42 aggregation to bemeasured. The
initiation of aggregation was accompanied by a decrease in density
without signiﬁcant changes in thickness whilst during the elongation
and higher order aggregate an abrupt increase in thickness was obtain-
ed [100].
Membranes play an important role in mediation of the conforma-
tional changes, initiation of lowmolecular weight oligomers, nucleation
of mature ﬁbrils and alteration of structural morphology with speciﬁc
pathological features. Studying the time-resolved formation of peptide
and protein aggregates on a membrane template will help to under-
stand the factors involved in initiating and modulating aggregation
and the arrest of ﬁbril formation by inhibitors of aggregation. SPR-
based techniques have been used to study the membrane interaction
of amyloidogenic molecules [101]. However, waveguide-based optical
sensors have been employed to simultaneously characterise the binding
kinetics and structural changes during the association of aggregated
species in supported membrane systems. The changes in the optical
properties of the membranes that occur during the process of time-dependent peptides/proteins aggregations have been shown for Aβ40
[102], prion proteins [92] and α-synuclein [76].
The role of raft domains in model neuronal membranes on the be-
haviour of raft-dependent Aβ aggregation has been characterised by
the spectral shift of s- and p-polarisation obtained with PWR spectros-
copy [102]. Aβ40 peptides bind to all model membranes composed of
DOPC, sphingomyelin (SM), SM/Chol, DOPC/SM/Chol whilst only aggre-
gates bind in the presence of SM.With the presence of cholesterol in the
SM bilayers, a 5-fold stronger binding than to DOPC and SM-only bilay-
ers was accompanied by a mass loss attributed to the removal of lipid
molecules from the bilayer and transfer to the Gibbs border, which oc-
curs upon peptide insertion into the bilayer and aggregation leading
to lipid displacement. The ability of Aβ to preferentially bind and insert
into the densely packed thicker SMmicrodomain over the less-ordered
thinner DOPC domain was characterised as a biphasic binding process
on the DOPC/SM/Chol ternary lipid bilayers. A transition from an initial
positive spectral shift to a negative spectral shift with increasing
membrane-bound peptide mass allowed the process of binding, in-
sertion and bilayer expansion to be observed for Aβ aggregation on
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in the optical properties (RI and thickness) of lipid bilayers during the
process of Aβ binding and aggregation were quantitatively charac-
terised by spectral simulation of the experimental spectral parameters,
which provided further understanding of the effect of amyloid aggrega-
tion on membrane perturbation. No change in the bilayer properties
was observed during the initial Aβ binding to the bilayer surface of
DOPC and SM, whilst a large decrease in the RI was observed for the
cholesterol-containing bilayers, which facilitated the insertion and ag-
gregation of Aβ involving bilayer reorganisation. PWR analysis com-
bined with liposome dye-release and cryo-TEM of the binding of
various Aβ1–42 variants to DOPG bilayers showed the effect of oligo-
meric aβ1–42 on membrane perturbation and cell toxicity [103].
PWR has also provided insight into the changes in the mass density
and structural ordering of the amyloid-membrane complex [51,104].
Whilst the interaction of non-toxic (WT) and toxic HET-s prion peptides
with asolectin, DOPC and DPPG membranes showed increases in the
resonance angle position, the role of lipids in mediating the binding
and aggregation of HET-s could be further differentiated by resolving
the magnitude if the angle shift, the rate of binding and the extent of
the membrane reorganisation. Larger spectral shifts were observed for
peptides binding to the negatively charged DOPG membranes indicat-
ing the importance of electrostatic interactions in promotingpeptide ac-
cumulation. In addition, an increase inmembrane thickness of 3 nmwas
observed for binding of the non-toxic and toxic HET-s prion to theDOPG
bilayer. In contrast, the splitting of the resonance minimum of the s-
polarisation data was related to the formation of microdomains for dif-
ferent organisations of bound peptide. The interaction of toxic protein
with DOPG formed three domains with different thicknesses; 60% of
the membrane area showed no change in thickness whilst 25% showed
an increase of 6 nm and 15% showed an increase thickness of 10 nm
upon binding of the toxic prion aggregate. However, no signiﬁcant dif-
ference was observed for the binding kinetics of either the toxic or
non-toxic prion aggregate. Thus, lateral membrane reorganisation of
different microdomains with different optical properties can be mea-
sured as splitting in the resonance spectra. However, unlike ligand–
receptor interactions, the afﬁnity constants for amyloid–membrane
interactions cannot be accurately determined for the complex coherent
changes associated with peptide–lipid interactions, membrane reorga-
nisation and protein self-assembly.
The changes in the optogeometrical properties for the binding and
during the process of amyloid formation on the membrane have also
been characterised for the prion proteins [92] and α-synuclein using
DPI which provide insight into early events in the aggregation [76].
Based on the DPI phase shift data, the extent of aggregation was signif-
icantly enhanced by the electrostatic interaction between the positively
charged PrP peptide and negatively charged POPS lipid bilayer resulting
in a thicker and more densely packed protein layer compared to those
on POPC bilayers. In addition, further growth of the protein aggregate
layer, as indicated by increases in both TM and TE phases, was observed
upon incubation of PrP on POPC/POPS bilayer.
The role of lipid composition on α-synuclein aggregation and the
impact of aggregation on bilayer properties were also characterised by
the changes of the optical properties in SLBs and liposomes tethered
on DPI chip surfaces [76]. Strong binding was mediated by the electro-
static interaction with the DOPS-containing bilayers. α-Synuclein
binding was further enhanced by increasing the DOPE content in theTable 2
Molar ratio of peptide to lipid determined at the point where mass loss and membrane
disruption.
DMPC DMPC/DMPG (4:1)
Aurein 1.2 1:14 1:23
Magainin 2 – 1:15
Ala8,13,18-Magainin 2 1:8 1:13membranes. By following the variations in mass and birefringence
upon α-synuclein binding, the protein–lipid stoichiometry for these
changes in the optical properties of bilayers was correlated with the
mode of interaction. Two processes forα-synuclein binding to different
SLBs except DOPC suggested the initial binding caused membrane ex-
pansion as a result of insertion followed by a second stage of surface
binding without a change in bilayer order. The bilayer disorder induced
byα-synuclein showed a lowdegree of reversibility after rinsing. By com-
paring the optical properties of SLBs and tethered liposomes, amembrane
remodelling mechanism was proposed for the α-synuclein–membrane
interaction, in contrast to the transmembrane insertion adopted by
AMPs. Speciﬁcally,α-synuclein binding tomembranes involved insertion
at the head group region leading to lateral expansion of lipids. The partial
insertion was then facilitated and enhanced by defects in lipid packing
and the expansion of lipid resulted in the membrane remodelling and
thinning.
Overall, the amyloid layermay be anisotropic and its formation onto
an existing anisotropic layer may modulate the overall birefringence.
However, the formation of the anisotropic peptide assembly may also
induce disordering in the bilayer. In addition, amyloid formation is a ki-
netic process and the molecular mechanism of amyloid deposition may
follow a wide range of pathways which may include rod-like assembly
formation in addition to sheets, spheroids etc. Therefore, new tech-
niques are required to resolve the birefringence changes associated
with these systems.
5.3. Apoptotic peptides
Mitochondrial outer membrane permeabilization (MOMP) is con-
sidered the initial step in intrinsic apoptosis with the formation of the
apoptotic pore, which has been related to the release of pro-apoptotic
mitochondrial resident proteins including cytochrome c (cyt c) and
smac/diablo to the cytosol and subsequent activation of caspases. The
function of the Bcl-2 proteins in apoptosis has been linked to their direct
interaction with the mitochondrial membrane leading to MOMP. In re-
cent years the role of lipids in the Bcl-2 regulated apoptotic pathwayhas
been recognised and is central to the “embedded together” model
[105–107]. This draws together aspects of both direct and indirect acti-
vation but also takes into account the importance of mitochondrial
membranes in facilitating key interactions such as those involved in
the activation of Bax by the BH3-only protein tBid, and the inhibition
of Bax oligomerisation by the anti-apoptotic family members. The pre-
cise role of themembrane in these interactions, however, is still unclear.
More speciﬁcally, an understanding of the functional role of Bcl-2
protein secondary structure variation caused by protein–membrane
interactions and its effect on relative membrane afﬁnity and disorder
will be central to understanding the events that lead to MOMP.
Recent studies in this area seek to further our understanding of the
mechanism bywhich the Bcl-2 proteins interact with themitochondrial
and plasmamembranes, and in turn how thesemembranes are restruc-
tured upon protein contact. A membrane perturbation study based on
the birefringence analysis has been focused particularly on the hydro-
phobic C-terminal trans-membrane domain (TMD) of Bcl-2 proteins
interacting withmembrane mimics including plasmamembrane, mito-
chondrial outer membrane and mitochondrial outer membrane with
cardiolipin (Fig. 5) [93]. Bcl-2 related peptides bind selectively to mi-
tochondrial mimics over plasma membrane mimics and that anti-
apoptotic peptides exert a different effect on the bilayer to pro-
apoptotic peptides (Fig. 5). Most signiﬁcantly membrane binding be-
haviour of transmembrane domain-derived synthetic peptides indi-
cate an activity-based classiﬁcation of these peptides in which there
is a clear correlation between the membrane disruptive properties
and the biological activity [93]. The TMD peptides preferentially
bound to mitochondrial membranes that in turn induce conforma-
tional changes in the peptides. The TMD peptides did not perturb
plasma membranes and were therefore non-toxic to cells, however
Fig. 4. The changes in the molecular order of supported DMPC bilayers induced by the alanine substituted magainin 2 (Ala8,13,18-mag2) showed a multi-stage process of membrane
destabilisation with increases in membrane-bound peptide mass. The extent of bilayer disordering from binding leading to membrane expansion correlated well with the sequential
changes of spreading of lipid molecules on the solid support bilayer imaged in real-time by AFM. The peptide induced membrane expansion involves the interconversion of multiple
conformation states (A, B and C) of the peptide–lipid complexes. The peptides were injected consecutively onto the DMPC bilayer from 1.25 to 40 μM with a 2-fold increment in
concentration. The association and dissociation of Ala8,13,18-mag2 are denoted by the solid arrow and dotted line, respectively. * corresponds to the initial membrane disordering and
** corresponds to the onset of membrane disruption with mass loss. (Adapted from [74]).
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mitochondria inducing MOMP and caused cell death (Fig. 5). Impor-
tantly, at sub-lethal doses, the TMD peptides exerted a mitochondrial
priming activity that enhances the cell death-inducing properties of
the chemotherapeutic drug cisplatin. These results clearly show that,
even the examination of isolated transmembrane domain can provide
signiﬁcant insight into the role of the mitochondrial Bcl-2 protein re-
cruitment. In particular, the ability to measure comparative changes in
membrane structure of a model plasma membrane and mitochondrial
membrane by DPI has provided signiﬁcant new insight into the mecha-
nismof apoptoptic pore formation by Bcl proteins. These studies also lay
the foundation for understanding selectivity of Bcl proteins for mito-
chondrial membrane relative to the plasma membrane and the role of
this selectivity in apoptosis and development of cancer therapeutics.6. Kinetic analysis of experimental data to deﬁne
binding mechanisms
Most studies of membrane-active peptides have focused on the
overall mechanism—either in terms of the actual efﬁcacy of the peptide
such as cell lysis and cargo transport or the ﬁnal end-point of mecha-
nisms such as pore formation or micellisation. However, in order to
fully understand themechanismof action of thepeptides, it is important
to characterise the sequence of events involved in the entire dynamic
process. For example, a peptide may bind the membrane, reorient
with different topology, insert further into the membrane, destabilise
the membrane, and then interact with other peptides to form pores or
other structural assemblies. Much research limits itself to either the ini-
tial peptide binding step with respect to the surface charges or the for-
mation of the ﬁnal structure of the lipid–peptide complex, neglectingthe intermediate steps. However, these intermediate steps may well
be critical for the peptide to achieve its function, and understanding
these steps may lead to new opportunities for peptide design in thera-
peutics. The question that must be asked is not merely what overall
mechanism(s) are involved, but what the intermediate steps are, and
what factors may affect the sequence of transitions that lead to the
ultimate activity of the peptide. Determining the intermediate states re-
quires a thorough characterisation of peptide andmembrane structural
changes and the kinetics associated with different intermediate steps.
This information is now emerging with optical waveguide technologies
through kinetic analysis of real-time binding data using speciﬁc kinetic
models andwill enable the design of peptides tomodulate their activity
resulting inmore powerful and ﬂexible use formechanistic understand-
ing of biomolecular membrane interactions.
6.1. Kinetic models
Kinetic models, with regard to peptide–membrane interactions, are
an approximate mathematical representation of the process by which
a peptide will bind to the membrane. A simple example of such a
model is the one-state model (sometimes called “Langmuir binding”)
in which the peptide binds and dissociates with the membrane at
concentration-dependent rates [29]. The peptide does not change
state at the membrane, and there is only one way in which it may
bind. This may be represented by the reaction:
P þ L↔PL
where P represents the peptide free in solution, L represents the un-
bound lipid membrane, and PL represents the complex formed by the
binding of the peptide to the membrane. Kinetic models are modelled
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various states in substances, in this case the reaction is deﬁned by the
equation:
dM
.
dt
¼ ka1CPMmax− kaCP þ kdð ÞM
However it has been found that this model provides an inadequate
representation of binding processes [108], and more sophisticated
models must be used. A more complex model is the two-state model
[108], so called because the peptide forms one state on initial binding
to the membrane, and then undergoes a transition to a second state
once it is bound. This may be represented by the reaction:
P þ L↔PL1↔PL2
and mathematically by the system of differential equations
dM1
.
dt
¼ ka1CP Mmax−M1−M2ð Þ−kd1M1−ka2M1 þ kd2M2
dM2
.
dt
¼ ka2M1−kd2M2
Further elaborations upon this model are possible; the three-state
model [108] is the logical extension where the bound peptide, already
in its second bound state, may undergo a transition to a third state.
Parallel reactions models involve simultaneous reactions. In a simple
case this may involve two one-state reactions; in more complex cases
some or all reactionsmay havemultiple states. Also, in any of above de-
scribed models, there may be co-operativity in the reactions, i.e. inter-
actions between peptides on the surface may speed up the transition
from one state to another.
The three-state model, which will be discussed extensively in the
next section, is represented by the equations
dM1
.
dt
¼ ka1CP Mmax−M1−M2ð Þ−kd1M1−ka2M1 þ kd2M2
dM2
.
dt
¼ ka2M1−kd2M2−ka3M2 þ kd3M3
dM3
.
dt
¼ ka3M2−kd3M3
6.2. Incorporation of birefringence into kinetic models
The models described above are typically used in kinetic modelling
with only one dependent variable, mass. This restricts the ability to dif-
ferentiate between the more complexmodels, as shown by the binding
of the antimicrobial peptide HPA3 to the unsaturated zwitterionicFig. 5. Themembrane binding properties of peptides corresponding to the transmembrane dom
order as a function ofmembrane-boundpeptidemass using DPI. (a) For both Bcl-w and Bak pep
bilayer order measured by birefringence (Δnf). In contrast to the Bcl-w TMD peptide, TMD-Ba
lower TMDpept concentration was required to induce signiﬁcant perturbations to the cardiolip
between thebilayer perturbation (Δnf) ofMito-likemembrane, calcein release induced by TMDp
(Adapted from [93]).bilayer POPC (Fig. 6) [108]. Assumingno structural changes in themem-
brane using only the mass, the process can be very well ﬁt by the two-
state model, and the three-state model only provides a very slight im-
provement to the ﬁt. From this, one might conclude that there are
only two signiﬁcant states involved in the binding of this peptide. How-
ever, when considering themembrane structural changes, themeasure-
ments of membrane order, represented by birefringence, are now also
included in the analysis. This is based on the assumptions that peptide
bound to the membrane changes the birefringence of the membrane,
and that the change in birefringence is linearly proportional to the
change in mass. However, different states of the peptide may have dif-
ferent levels of impact on the membrane; for example, a peptide
bound to the surface may only have a small impact on birefringence,
whilst the same peptide when fully inserted may have a much larger
impact. This is mathematically modelled with the following algebraic
equations that link the birefringence to the mass of peptide in its states.
For the two-statemodel:
nf ¼ n1M1 þ n2M2
For the three-statemodel:
nf ¼ n1M1 þ n2M2 þ n3M3
Where n1, n2, n3 are constants speciﬁc to the interaction taking place.
These models have been applied to binding mechanism of the pep-
tide HPA3 [108]. By ﬁtting these parameters to the model it becomes
clear that the two-statemodel is inadequate for the above reaction, as
it gives a poor ﬁt and does not account for the characteristics of the
binding curve (Fig. 6). However, using a three-state model provides a
much better ﬁt, including the notable downward kink in the ﬁnal stages
(Fig. 6). This shows that simultaneously measure both mass and bire-
fringence, additional steps in the binding process may be revealed that
previous technologies measuring the mass-only changes could not
have shown. In contrast, there was only a slight improvement in the
ﬁt to the binding proﬁles of HPA3 to the saturated DMPC bilayer
below the transition temperature when using the three-state model.
The two-state model already gave a good ﬁt suggesting that there are
only two signiﬁcant states that impact on mass or birefringence [29].
This analysis allowed the calculation of the normal association and
dissociation constants as frequently described in kinetic analysis, but
in addition, it also determines additionalmembrane disordering param-
eters that quantify the birefringence–mass relationship for each state of
the reaction, with larger numbers indicating a greater impact on mem-
brane structure per unit of peptide in that particular state. For example,ain peptides (TMDpept) of Bcl-2 family members were assessed by the changes in bilayer
tides binding to POPC (Black Line), a plasmamembrane-likemodel, there is little change in
k induced signiﬁcant bilayer perturbation of the Mito-like membrane (Green Line) and a
in-containingMito-like membranes (Red Line). (b) The results showed a good correlation
epts and the loss of themembranepotential of isolatedmitochondrial and the cell viability.
Fig. 6. The binding of HPA3 to supported DMPC bilayer analysed by a two-state and a three-state bindingmodel showing the relative proportions of the peptide in each state according to
the parameters of the model. The three-state ﬁtting programme can deconvolute both mass changes and bilayer disordering into sequential steps of peptide insertion into membrane
involving the component of bilayer expansion. However, the two-state model poorly ﬁt the binding and changes in bilayer order. (Adapted from [108]).
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using a three-state model are−0.0048 for state 1, −0.0042 for state
2, and a much larger value −0.0274 for state 3. From this it can be
seen that whilst the ﬁrst two states had a similar impact on the mem-
brane birefringence, the third state had a much larger effect [108].
The results of the model can easily be graphed to visualise the
proportions of peptide in various states as the dynamic changes in
membrane progress and is shown for HPA3 on POPC in Fig. 6. Here
it can be seen that the amount of peptide in State 1 rises very rapidly
at the start of the injection, but then falls away gradually as it pro-
gressively converts to State 2. Once the injection is complete the
peptide in State 1 rapidly dissociates, but the peptide in State 2 re-
mains bound and gradually converts to State 3 [108]. This approach
has also been recently applied to the analysis of the intracellular
Helix 8 of the angiotensin II type 1A receptor and has highlighted a
signiﬁcant role of phosphatidylinositols in the regulation of this re-
ceptor during signalling [109].
7.Membraneorderingproﬁles: new insight into biological processes
Membrane bilayer components alter the physiological proﬁles of a
vast number of membrane proteins, either through speciﬁc interactions
with the protein itself or alteration of membrane physical properties
such as curvature, lateral pressure, and bilayer thickness [1,5]. For a
large number of cases, the available evidence points to a clear link be-
tween peptide/protein structure/function, and the surrounding mem-
brane composition. For example, as discussed above, antimicrobialpeptide action is controlled by the nature of the bacterial and mamma-
lian membrane [110], that the apoptotic cascade involving the Bcl-2
family of proteins is mediated by mitochondrial membrane proper-
ties [107] and that amyloid formation is induced and modulated by
membrane binding [111].
The data that is now available from techniques such as DPI provides
the opportunity to categorise membrane-mediated events in terms of
patterns of membrane structure changes. In particular mass–birefrin-
gence plots, which reveal the changes in membrane ordering that
occur during peptide binding, now allowvery detailed and subtle differ-
ences in the interactions between lipids and peptides to be visualised.
This birefringence analysis provides novel information on the impact
of peptides on the changes in organisation occurringwithin a lipid bilay-
er, and assists in describing the behaviour of membrane-active peptides
when interacting with a lipid membrane. Overall a number of tran-
sitions can be described based on the birefringence vs. mass plots (as
illustrated in Fig. 7), which can be used to evaluate peptide behaviour
andmechanism of action and are the centrepiece of this newmembrane
biophysical methodology. The molecular events corresponding to these
four transitions are schematically drawn in Fig. 7 [12,72–74,99]. Com-
pared to reasonably similar overall proﬁles obtained by SPR, the wide
variety of membrane structure changes evident by DPI could not be an-
ticipated and has opened up exciting opportunities for more detailed
understanding of a vast range ofmembrane-mediated biological events.
The examples described above demonstrate how knowledge of the
membrane structure changes signiﬁcantly informs our understanding
of a wide range of biological processes.
Fig. 7. Themolecular mechanism of membrane disruption consists of a series of intermediate states, each representing an ensemble of closely-related bilayer structures. For the examples
of antimicrobial peptides and apoptotic peptides induced bilayer disordering, three general membrane-inserted states are deﬁned corresponding to (1) surface parallel-bound state (a–c),
(2) partially inserted state (d–f) and (3) signiﬁcantly inserted state with membrane lysis or expansion (g–i).
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dent in Fig. 3, newmodels can be deﬁned for the molecular mechanism
of action in terms of a series of intermediate states, each representing an
ensemble of closely-related bilayer structures, such as depicted sche-
matically in Fig. 7 for antimicrobial peptides and apoptotic peptides. In
this example, three general membrane-inserted states are outlined cor-
responding to (1) surface-bound peptides (Fig. 7a–c), (2) partially
inserted peptides (Fig. 7d–f) and (3) signiﬁcantly inserted peptides
(Fig. 7g–i). This model also describes alternate pathways of interme-
diate membrane states that occur in the presence of increasing
amounts of bound peptide; the prevalence of each state is dependent
on the peptide and the lipid composition. This model, based on bire-
fringence changes at critical mass loadings, allows the properties of
membrane-active peptides to be analysed in terms of surface bind-
ing, insertion, membrane opening and bilayer lysis, and in more de-
tail than has been previously possible in terms of dynamic structural
changes. In particular, the molecular events prior to membrane lysis
can be fully characterised in terms of bilayer structural changes and
provides new criteria that can guide the design of selective antibac-
terial peptides.8. Final considerations and future directions
The knowledge of structural changes associated with biomolecu-
lar interactions underpins the deﬁnition of a molecular mechanism.
For membrane structure changes, we conventionally require multi-
ple techniques to develop a picture of membrane interactions of
any particular class of peptides/protein. The optical biosensors de-
scribed in this review now allow rapid measurement and deﬁnition
of membrane structure change, recovery and repair of any mem-
brane–peptide/protein set or interacting partners.
These and many other examples clearly demonstrate that the
membrane bilayer is an active participant in an enormous number
of biological processes. However, despite these established para-
digms, the complete lack of molecular details of the changes inmem-
brane structure during the binding and action of a peptide or protein
is severely restricting new progress, ﬁrstly in deﬁning these biologi-
cal processes in the detail required to fully understand the mecha-
nism, and secondly to exploit this understanding in the design of
new therapeutics to modulate these processes where their dysregu-
lation underpins disease.
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complex biological processes, the ‘how’, ‘when’ and ‘why’ of this rela-
tionship remains less clear and, if we are to fully understand these
systems, themembrane must be a strong focus of future studies. Deter-
mininghow these concepts apply to other systemswill only be achieved
through detailed investigations on membrane structures, which until
now have been severely hampered by the lack of techniques to readily
measure membrane structure changes in real-time. DPI (Fig. 1c) now
makes membrane structure analysis amenable to biophysical investiga-
tions, allowing us to characterise how themembrane controls the func-
tion of a number of biological systems through a systematic analysis of
membrane structure. In addition, the complication of linear dichroism
and birefringence of protein assembly such as the formation of rod-
like amyloid on the anisotropic properties of lipid bilayer require more
complex models to resolve the overall changes in birefringence for
several distinctive layers.
Collectively, the techniques and results reviewed here demonstrate
that this unprecedented knowledge of membrane structural change
proﬁles provides signiﬁcant new insights into membrane-mediated
processes. Not only does this information provide a more detailed mo-
lecular understanding of these events, but knowledge of the structure
changes associated with both the membrane as well as the interacting
ligands will open up new avenues for therapeutic intervention.
In summary, this substantial amount of new information on mem-
brane structure changes now sets the scene for a completely new
approach to studying membrane-mediated biological systems. The
unique advantage of DPI is that it allows real-time measurement of bi-
layer structure changes during peptide binding and results demonstrate
that themechanisms of bilayer disturbance differ signiﬁcantly between
different classes of peptides and proteins. The combination of DPI with
other biophysical techniques now opens the door to redeﬁning mole-
cular mechanism of biomolecular interactions in which the membrane
bilayer is a key player.
In this context the membrane–structure interaction proﬁles will
form the basis of amembrane structure “atlas”, analogous to the protein
structure atlas which is the cornerstone of protein structure and func-
tion studies. This membrane–structure Atlas will not only provide a ref-
erence of membrane behaviour to allow comparison of new data with a
data base of membrane proﬁles, but will lead to a new paradigm in the
role of the membrane as an interactive partner in biology and reveal
new approaches to therapeutic development.
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